Stem cell therapy for spinal cord injury

September 25, 2012
Stem cell therapy for spinal cord injury
Credit: Thinkstock

Stem cells are considered promising agents for the recovery of spinal cord injuries. European scientists explore their abilities and plan future therapeutic strategies.

remain without any specific therapy. Despite initial optimism from trials, neuroprotective molecules and poorly defined stem cells have not provided satisfactory controlled therapies.

The European project 'From stem cell technology to functional restoration after spinal cord injury' (Rescue) explored the ability of human stem cells to treat spinal cord damages. For that purpose, neural and non-neural stem cells were selected and evaluated in a rat model of spinal cord injury.

Resident stem cells in human and rodent spinal cord were successfully characterised. This achievement initiated a new long-term objective of the investigation of their fate in healthy and damaged rodent spinal cord.

A primary objective of Rescue was to decipher the safety of grafting adult from human biopsies. The experiments showed the formation of tumours from these grafts; therefore, novel optimised strategies are required.

Human neural precursor-derived were successfully differentiated showing promising results regarding axonal growth on collagen scaffolds. In addition, the adipose stromal stem cells performed better than the classical bone marrow preparation. Rescue scientists extensively examined the abilities of these cells in different scaffolds.

Rescue scientists worked intensively on the regulation of , especially regarding cell orientation and sorting. were targeted to the cells using different viral vectors. The vectors with the best conditions regarding proliferation ability and phenotype were selected for further transplantation studies. A novel was developed that might be suitable for clinical applications. Furthermore, the Rescue consortium created conditionally immortalised neural stem cell lines with very promising features.

The impact of Rescue's achievements in the field of stem cell-based therapies of damages and in particular of spinal cord injuries is significant. It was thoroughly demonstrated that stem cells intrinsic to the human spinal cord are a potential source of therapeutic cells and factors. Future research may focus on a comprehensive in detail characterisation of its phenotypes.

Explore further: Evidence for spinal membrane as a source of stem cells may advance spinal cord treatment

Related Stories

Evidence for spinal membrane as a source of stem cells may advance spinal cord treatment

October 28, 2011
Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential ...

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.